Patent · US Expired

Pyrrolopyrimidine derivatives

US7271262B2 · kind B2 · utility

53Cited by
2References
61Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2003
Grant dateSep 18, 2007
Priority date
Expiry dateJun 2, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of the formula 1or a pharmaceutically acceptable salt, prodrug or hydrates thereof, wherein Q, A, L, R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.